GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Return-on-Tangible-Equity

Huapont Life Science Co (SZSE:002004) Return-on-Tangible-Equity : 9.77% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Huapont Life Science Co's annualized net income for the quarter that ended in Sep. 2024 was ¥554 Mil. Huapont Life Science Co's average shareholder tangible equity for the quarter that ended in Sep. 2024 was ¥5,669 Mil. Therefore, Huapont Life Science Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was 9.77%.

The historical rank and industry rank for Huapont Life Science Co's Return-on-Tangible-Equity or its related term are showing as below:

SZSE:002004' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.37   Med: 12.98   Max: 15.36
Current: 4.37

During the past 13 years, Huapont Life Science Co's highest Return-on-Tangible-Equity was 15.36%. The lowest was 4.37%. And the median was 12.98%.

SZSE:002004's Return-on-Tangible-Equity is ranked worse than
57.55% of 245 companies
in the Agriculture industry
Industry Median: 6.25 vs SZSE:002004: 4.37

Huapont Life Science Co Return-on-Tangible-Equity Historical Data

The historical data trend for Huapont Life Science Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Return-on-Tangible-Equity Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.57 14.59 14.12 8.32 5.40

Huapont Life Science Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.49 -14.33 10.75 11.03 9.77

Competitive Comparison of Huapont Life Science Co's Return-on-Tangible-Equity

For the Agricultural Inputs subindustry, Huapont Life Science Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huapont Life Science Co's Return-on-Tangible-Equity Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Huapont Life Science Co's Return-on-Tangible-Equity falls into.



Huapont Life Science Co Return-on-Tangible-Equity Calculation

Huapont Life Science Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=302.122/( (5484.843+5712.803 )/ 2 )
=302.122/5598.823
=5.40 %

Huapont Life Science Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=553.82/( (5592.713+5745.358)/ 2 )
=553.82/5669.0355
=9.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Huapont Life Science Co  (SZSE:002004) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Huapont Life Science Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co Headlines

No Headlines